Due to the nearly homogeneous AR expression in PSA+ PCa cells (Supplementary Figure 4A; 13), primary HPCa and AD xenografts respond well to antiandrogens, leading to prominent reduction in tumor burden. The gene discussed is KLK3; the disease is neoplasm.